Watch Ticker

Passage Bio, Inc. Common Stock

Go to Passage Bio, Inc. Common Stock Website

$5.81

0.00 (0.00%)

Live

Previous Close

$5.81

Day Range

$0 - $0

Previous Day Range

$5.51 - $5.9899

Market Cap

$17.9 million USD

Day Vol.

Previous Day Vol.

18588

Currency

USD

Primary Exchange

Nasdaq

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Com...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Researchandmarkets.Com - 2025 Market Prospects of Adeno-Associated Virus Vectors in Gene Therapy Pipeline: 200 Pipeline Drugs and the Strategic Workings of 180+ Companies

The report provides a comprehensive analysis of the Adeno-Associated Virus (AAV) Vectors in Gene Therapy pipeline, highlighting the potential of this technology to revolutionize the treatment of genetic disorders. It examines the challenges in scalable production and safety, as well as the industry's focus on optimizing vectors for improved safety, specificity, and efficiency.

Related tickers: JNJ, PASG, RARE, MGTX, BIIB, RGNX, FDMT, ADVM, RCKT, RCKTW, SRPT, TNYA.

Read Full Article

N/A - Passage Bio to Participate in Upcoming Investor Conferences

Passage Bio, a clinical-stage genetic medicines company, announced that it will participate in upcoming investor conferences, including the TD Cowen 45th Annual Health Care Conference and the Leerink Global Biopharma Conference.

Related tickers: PASG.

Read Full Article

Trending Tickers

Please sign in to view